To overcome this issue, recent investigations are focusing on the characterization of other well-known receptors involved in breast cancer progression as potential therapeutic and imaging targets such as tyrosine kinases receptors, integrin receptors, chemokine receptors, immune checkpoint receptors, somatostatin receptors, gastrin releasing peptide receptors, and neuropeptide Y receptors. The gene discussed is GRPR; the disease is breast cancer.